Literature DB >> 4426393

Evidence for 'big' and 'little' components of circulating immunoreactive prolactin in humans.

K von Werder, C Clemm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4426393     DOI: 10.1016/0014-5793(74)80454-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Human prolactin: radioimmunoassay studies.

Authors:  O Lanigan; D Powell
Journal:  Ir J Med Sci       Date:  1978-07       Impact factor: 1.568

3.  Size heterogeneity of rat pituitary prolactin.

Authors:  M Wallis; M Daniels; S A Ellis
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

4.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

Review 5.  [Human prolactin (author's transl)].

Authors:  K von Werder; H K Rjosk
Journal:  Klin Wochenschr       Date:  1979-01-01

6.  Unusual heterogeneity of circulating prolactin in an acromegalic.

Authors:  A D Rogol; R C Eastman; T Manolio; S W Rosen
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

7.  Hormone-active intradural spinal metastasis of a prolactinoma--a case report.

Authors:  R Landgraf; G Rieder; P Schmiedek; D Clados; K Bise; K von Werder
Journal:  Klin Wochenschr       Date:  1985-04-15

8.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.